risks of taking tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Mounjaro, Zepbound Lowers Risk of

Authors Lucas Oliveira, Nutritionist, ProVeg International Anna-Lena Klapp, Head of Research, ProVeg International We would like to thank the following people for sharing their time, expertise, and thoughtful review of the brochure: Valentina Gallani, Health & Nutrition Manager, ProVeg International Veronika Mlynrik Baov, Senior Nutrition Specialist, ProVeg Czech Republic Laura Weinhold, Dietitian & Food Services Specialist, ProVeg Germany Stefany Guerreiro Lima, Food and Nutrition Project Manager, ProVeg Brasil Frequently asked questions What should I eat while on GLP-1 medication

Choose AOD-9604 If: Your main goal is targeting stubborn fat deposits like abdominal or visceral fat

While not a medical term, this is a real and increasingly common outcome of Ozempic use

But always speak to a professionalother conditions, like inner ear issues, can cause similar symptoms

Compounded products are not FDA-approved and are not interchangeable with brand-name tirzepatide, but the active peptide behaves the same way once injected

GLP-1 receptor agonists caused dose-dependent thyroid C-cell tumors in rodent studies